Defining incident chronic kidney disease in the research setting

American Journal of Epidemiology

Volumn 170, Issue 4, 2009, Pages 414-424

  Bash, Lori D ^a,b   Coresh, Josef ^a,b,c   Köttgen, Anna ^a,b   Parekh, Rulan S ^a,b,c   Fulop, Tibor ^d   Wang, Yaping ^a,b   Astor, Brad C ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Cohort studies; Diagnostic techniques and procedures; Incidence; Kidney diseases

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD SYSTEM DISORDER; CAUSE OF DEATH; COHORT ANALYSIS; DIABETES; DISEASE INCIDENCE; EPIDEMIOLOGY; HYPERTENSION; LIPID; RISK FACTOR; SERUM; TEMPORAL ANALYSIS;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COMORBIDITY; CREATININE; DATA COLLECTION; EPIDEMIOLOGIC METHODS; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 68149183962     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp151     Document Type: Article

References (39)

1. Hsu CC, Kao WH, Coresh J, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005;293(23): 2892-2899.
2. Hsu CC, Bray MS, Kao WH, et al. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol. 2006; 17(2): 504-512.
3. Merkin SS, Coresh J, Diez Roux AV, et al. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2005;46(2): 203-213.
4. Shoham DA, Vupputuri S, Diez Roux AV, et al. Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2007;49(2): 217-226.
5. Young JH, Klag MJ, Muntner P, et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002;13(11):2776-2782.
6. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39-48.
7. Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham predictive instrument in chronic kidney disease. JAm Coll Cardiol. 2007;50(3):217-224.
8. Stengel B, Couchoud C, Helmer C, et al. Epidemiology of chronic kidney disease in France. Presse Med. 2007;36(12 pt 2):1811-1821.
9. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1-12.
10. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2005;45(1 suppl 1):A5-A7, S1-S280.
11. DuBose TD Jr. American Society of Nephrology Presidential Address 2006: chronic kidney disease as a public health threat-new strategy for a growing problem. J Am Soc Nephrol. 2007; 18(4): 1038-1045.
12. Kramer HJ, Nguyen QD, Curhan G, et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273-3277.
13. Haroun MK, Jaar BG, Hoffman SC, et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14(11):2934-2941.
14. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1): 13-18.
15. Robinson BE. Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc. 2006;7(9 suppl):S3-S6, quiz S17-S21.
16. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16(1):180-188.
17. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702.
18. Papp AC, Hatzakis H, Bracey A, et al. ARIC hemostasia study-I, Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61(1):15-19.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
20. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39(5):920-929.
21. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1): 47-55.
22. Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. JAm Soc Nephrol. 2007;18(10):2749-2757.
23. Eckfeldt JH, Chambless LE, Shen YL. Short-term, withinperson variability in clinical chemistry test results. Experience from the Atherosclerosis Risk In Communities Study. Arch Pathol Lab Med. 1994;118(5):496-500.
24. Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the Atherosclerosis Risk in Communities Study. Kidney Int. 2000;58(1):293-301.
25. Krop JS, Coresh J, Chambless LE, et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159(15):1777-1783.
26. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Washington, DC: Health Care Financing Administration, Public Health Service, US Department of Health and Human Services; 1991.
27. StataCorp LP. Stata statistical software: release 9.2. College Station, TX: Stata Corporation; 2003.
28. StataCorp LP. Stata statistical software: release 10.0. College Station, TX: Stata Corporation; 2007.
29. Bash LD, Selvin E, Steffes M, et al. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med. 2008; 168(22):2440-2447.
30. Bash LD, Erlinger TP, Coresh J, et al. Inflammation, hemostasia, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009;53(4):596-605.
31. Mehrotra R, Kermah D, Fried L, et al. Racial differences in mortality among those with CKD. J Am Soc Nephrol. 2008; 19(7): 1403-1410.
32. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14(2):469-477.
33. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 10. 2006 Dec;(232):1-153.
34. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2005.
35. Perneger TV, Whelton PK, Klag MJ, et al. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol. 1995;141(1 ): 10-15.
36. Brenner & Rector's The Kidney. 7th ed. Philadelphia, PA: WB Saunders; 2004.
37. Winkelmayer WC, Schneeweiss S, Mogun H, et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005;46(2):225-232.
38. Kern EF, Maney M, Miller DR, et al. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res. 2006;41(2):564-580.
39. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl. 1): S1-S266.